Back to top
more

British American Tobacco (BTI)

(Real Time Quote from BATS)

$35.82 USD

35.82
276,646

+0.18 (0.51%)

Updated Nov 7, 2024 09:58 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (48 out of 251)

Industry: Tobacco

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Vrishali Bagree headshot

3 Tobacco Stocks to Watch on Impressive Industry Trends

by Vrishali Bagree

The Zacks Tobacco industry players are benefiting from solid pricing power as well as focus on innovation and expansion of low-risk products. These upsides bode well for Philip Morris (PM), British American Tobacco (BTI) and Turning Point Brands (TPB).

Shaun Pruitt headshot

Should Investors Buy Big Tobacco Stocks?

by Shaun Pruitt

With their total returns being impressively better than the broader market this year, investors might want to consider these equities for 2023 as well.

British American Tobacco (BTI) Recently Broke Out Above the 20-Day Moving Average

by Zacks Equity Research

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

British American Tobacco (BTI) Crossed Above the 200-Day Moving Average: What That Means for Investors

by Zacks Equity Research

Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?

Zacks Value Investor Highlights: Hess Corporation, Cleveland-Cliffs, British American Tobacco, KraftHeinz and GATX

by Zacks Equity Research

Hess Corporation, Cleveland-Cliffs, British American Tobacco, KraftHeinz and GATX have been highlighted in this Value Investor article.

Tracey Ryniec headshot

Diving Into Berkshire Hathaway's 1970s Investing Playbook

by Tracey Ryniec

What can we learn from what Warren Buffett was up to during the high inflation of the 1970s?

British American Tobacco (BTI) Just Overtook the 20-Day Moving Average

by Zacks Equity Research

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

Zacks Investment Ideas feature highlights: Philip Morris International Inc., Altria Group, Inc. and British American Tobacco p.l.c

by Zacks Equity Research

Philip Morris International Inc., Altria Group, Inc. and British American Tobacco p.l.c are highlighted in this Investment Ideas article.

Bryan Hayes headshot

3 Defensive Stocks Breaking Out to New 52-Week Highs

by Bryan Hayes

3 Defensive Stocks Breaking Out to New 52-Week Highs

Philip Morris' (PM) IQOS, Beyond Nicotine Growth Plans On-Track

by Zacks Equity Research

Philip Morris (PM) benefits from the growing market for IQOS devices globally. It is also focused on the expansion of Beyond Nicotine products to support inhaled therapeutics.

Focus on Low-Risk Offerings Drives Altria (MO), Pricing Aids

by Zacks Equity Research

Altria (MO) strives to expand IQOS and on! amid consumers' rising preference on low-risk tobacco alternatives. Moreover, strong pricing for tobacco products is driving revenues.

Altria (MO) to Divest Ste. Michelle Wine Estates Business

by Zacks Equity Research

Altria's (MO) subsidiary agrees to sell Ste. Michelle Wine Estates business. The move will boost shareholders' value, while aiding in smooth transition of adult smokers to a non-combustible future.

Philip Morris (PM) Up 10% in 3 Months, Gains on Pricing & RRPs

by Zacks Equity Research

Philip Morris (PM) is gaining from rising popularity of IQOS devices. Additionally, pricing power, especially for combustible products, is an upside.

Altria (MO) Gains on Low-Risk Tobacco Offerings, Strong Pricing

by Zacks Equity Research

Altria's (MO) low-risk and oral tobacco offerings are gaining popularity. Moreover, high pricing for tobacco products is an upside.

Philip Morris (PM) Benefits From IQOS Growth & Strong Pricing

by Zacks Equity Research

Philip Morris (PM) gains from growth in the RRPs category, backed by rising popularity of IQOS devices. Additionally, pricing power, especially for combustible products, is an upside.

Altria (MO) Sees Growth in Low-Risk Products, Pricing Aids

by Zacks Equity Research

Altria's (MO) low-risk tobacco offerings such as IQOS and on! are gaining popularity. Moreover, high pricing for tobacco products are an upside..

Altria (MO) Looks Steady on Low-Risk Products & Strong Pricing

by Zacks Equity Research

Altria (MO) gains from the popularity of low-risk tobacco alternatives such as IQOS. Moreover, strong pricing for tobacco products supports revenues.

Philip Morris (PM) Gains on RRPs Popularity & Pricing Power

by Zacks Equity Research

Philip Morris' (PM) IQOS devices are gaining traction among consumers. Moreover, pricing power, especially for combustible products, is an upside.

Altria (MO) Benefits From Low-Risk Products & Pricing Power

by Zacks Equity Research

Altria (MO) gains from expansion of IQOS and oral tobacco offerings such as on! Moreover, pricing power is aiding revenues.

Altria (MO) Poised on Solid Pricing, Growth in Low Risk Products

by Zacks Equity Research

Altria (MO) gains from rising popularity of IQOS and oral tobacco offerings. Moreover, pricing power is supporting revenue growth.

Phillip Morris (PM) Poised for Growth on RRPs & Strong Pricing

by Zacks Equity Research

Philip Morris' (PM) strong offerings in the reduced risk products space and solid pricing of combustible products are driving growth.

Altria (MO) Gains on Low Risk Tobacco Products & Strong Pricing

by Zacks Equity Research

Altria's (MO) efforts to boost oral tobacco offerings and expansion of IQOS across stores are yielding. Moreover, pricing power is aiding revenue growth.

Will RRPs Growth Keep Driving Philip Morris (PM) in 2021?

by Zacks Equity Research

Philip Morris (PM) is gaining from growing popularity of IQOS, which is boosting revenues in the RRPs category.

Altria (MO) Gains on Low-Risk Products Amid Soft Cigarette Sales

by Zacks Equity Research

Altria (MO) is gaining from the popularity of low-risk tobacco alternatives such as IQOS and on!, as well as prudent pricing strategies.

Philip Morris's (PM) IQOS 3 Receives FDA Authorization for Sale

by Zacks Equity Research

FDA approves the sale of Philip Morris's (PM) IQOS devices in the United States. The latest device includes a number of technological advancements compared with its predecessors.